bioMerieux (BMXMF)
(Delayed Data from OTC)
$105.67 USD
0.00 (0.00%)
Updated Apr 26, 2024 10:26 AM ET
4-Sell of 5 4
C Value B Growth C Momentum C VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Top 34% (85 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.67 | 1.51 | 9.99 |
Current Quarter Estimate | NA | -0.48 | 60.00 |
Year Ago Quarter Estimate | NA | 0.07 | 52.54 |
Next Quarter Estimate | NA | 1.48 | 61.00 |
Next Year Estimate | 5.03 | 8.09 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 35.89 | 12.30 | 17.08 |
Next Year | 13.54 | 21.40 | 8.00 |
Last 5 Years | 5.70 | 9.50 | 8.10 |
Next 5 Years | NA | 15.20 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 17.34 |
Price/Book (MRQ) | 3.15 | 1.88 |
Price/Cash Flow (MRFY) | 17.92 | 13.24 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | 4.68% |
Return on Equity (TTM) | NA | 9.69% |
Debt to Equity (MRQ) | NA | 28.34 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.